Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders Are Encouraged to Contact the Firm – RP, OXFD, FFG, MDCA, ALXN, CHNG

NEW YORK, Jan. 30, 2021 /PRNewswire/ — Halper Sadeh LLP, a global investor rights law firm, continues to investigate the…

NEW YORK, Jan. 30, 2021 /PRNewswire/ — Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies:

RealPage, Inc. (NASDAQ: RP) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Thoma Bravo for $88.75 in cash per share. If you are a RealPage shareholder, click here to learn more about your rights and options.  

Oxford Immunotec Global PLC (NASDAQ: OXFD) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to PerkinElmer, Inc. for $22.00 in cash per share. If you are an Oxford shareholder, click here to learn more about your rights and options.

FBL Financial Group, Inc. (NYSE: FFG) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Farm Bureau Property & Casualty Insurance Company for $56.00 per share in cash. If you are an FBL shareholder, click here to learn more about your rights and options.  

MDC Partners Inc. (NASDAQ: MDCA) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Stagwell Media LP. Stagwell and its affiliates are expected to hold approximately 79% of the common equity of the combined company after closing. If you are an MDC shareholder, click here to learn more about your rights and options.

Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to AstraZeneca PLC for $60.00 in cash and 2.1243 AstraZeneca American Depositary Shares for each Alexion share. If you are an Alexion shareholder, click here to learn more about your rights and options.  

Change Healthcare Inc. (NASDAQ: CHNG) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Optum, a company that is part of UnitedHealth Group. Under the merger agreement, Change Healthcare shareholders will receive $25.75 per share in cash. If you are a Change Healthcare shareholder, click here to learn more about your rights and options.

Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Halper Sadeh LLP

Daniel Sadeh, Esq.

Zachary Halper, Esq.

(212) 763-0060

sadeh@halpersadeh.com  

zhalper@halpersadeh.com  

https://www.halpersadeh.com

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/halper-sadeh-llp-continues-to-investigate-the-following-mergers-shareholders-are-encouraged-to-contact-the-firm–rp-oxfd-ffg-mdca-alxn-chng-301218461.html

SOURCE Halper Sadeh LLP